Covered recipient · General Payments record
RACHEL C JANKOWITZ
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2023
$6,024.61
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for serving as faculty or as a speaker for a medical education program | $614.75 | 1 |
| Food and Beverage | $365.54 | 3 |
| Travel and Lodging | $172.93 | 2 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $787.68 | 3 |
| Gilead Sciences, Inc. | $242.65 | 2 |
| Stemline Therapeutics Inc. | $122.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (6)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $135.69 | 01/31/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1025052377 | CMS |
| AstraZeneca Pharmaceuticals LP | $614.75 | 02/10/2023 | Compensation for serving as faculty or as a speaker for a medical education program | Undisputed | 01/23/2026 | 1025049831 | CMS |
| AstraZeneca Pharmaceuticals LP | $37.24 | 02/28/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1024990381 | CMS |
| Gilead Sciences, Inc. | $121.82 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025512981 | CMS |
| Gilead Sciences, Inc. | $120.83 | 10/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025514227 | CMS |
| Stemline Therapeutics Inc. | $122.89 | 12/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040035913 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.